Radionuclide 131I labeled reduced graphene oxide for nuclear imaging guided combined radio- and photothermal therapy of cancer

Biomaterials

Volumn 66, Issue , 2015, Pages 21-28

  Chen, Lei ^a,c   Zhong, Xiaoyan ^a   Yi, Xuan ^a   Huang, Min ^c   Ning, Ping ^a   Liu, Teng ^b   Ge, Cuicui ^a   Chai, Zhifang ^a   Liu, Zhuang ^b   Yang, Kai ^a  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

^c SUZHOU MUNICIPAL HOSPITAL   (China)

Author keywords

Combined therapy; Gamma imaging; Nano graphene; Radiolabeling; Radiotherapy

Indexed keywords

DISEASES; INFRARED DEVICES; NUCLEAR MEDICINE; RADIOTHERAPY; TOXICITY; TUMORS;

COMBINED THERAPY; GAMMA IMAGING; INTRAVENOUS INJECTIONS; PHOTOTHERMAL HEATING; PHOTOTHERMAL THERAPY; RADIOLABELING; REDUCED GRAPHENE OXIDES; THERAPEUTIC STRATEGY;

GRAPHENE;

MACROGOL; NANO GRAPHENE OXIDE I 131; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; GRAPHITE; NANOPARTICLE; OXIDE; RADIOACTIVE IODINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER RADIOTHERAPY; CONTROLLED STUDY; FEMALE; HEATING; IONIZATION; IRRADIATION; ISOTOPE LABELING; META ANALYSIS; MOUSE; NEOPLASM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTOTHERAPY; PRIORITY JOURNAL; RADIATION DOSE; RADIOACTIVITY; TISSUE DISTRIBUTION; TOXICITY TESTING; TUMOR MODEL; UPTAKE ASSAY; X RAY; ANIMAL; CHEMISTRY; IMAGE GUIDED RADIOTHERAPY; MULTIMODALITY CANCER THERAPY; NEOPLASMS, EXPERIMENTAL; PARTICLE SIZE; PATHOLOGY; PHOTOCHEMOTHERAPY; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; THERANOSTIC NANOMEDICINE; TREATMENT OUTCOME; TUMOR CELL LINE; ULTRASTRUCTURE;

ANIMALIA; MUS;

ANIMALS; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; GRAPHITE; IODINE RADIOISOTOPES; ISOTOPE LABELING; MICE; NANOPARTICLES; NEOPLASMS, EXPERIMENTAL; OXIDES; PARTICLE SIZE; PHOTOCHEMOTHERAPY; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RADIOTHERAPY, IMAGE-GUIDED; THERANOSTIC NANOMEDICINE; TREATMENT OUTCOME;

EID: 84938097827     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2015.06.043     Document Type: Article

References (52)

1. Walsh T.N., Noonan N., Hollywood D., Kelly A., Keeling N., Hennessy T.P.J. Acomparison of multimodal therapy and surgery for esophageal adenocarcinoma. New Engl. J. Med. 1996, 335:462-467.
2. D'Huyvetter M., Xavier C., Caveliers V., Lahoutte T., Muyldermans S., Devoogdt N. Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer. Expert Opin. Drug Deliv. 2014, 11:1939-1954.
3. Hamoudeh M., Kamleh M.A., Diab R., Fessi H. Radionuclides delivery systems for nuclear imaging and radiotherapy of cancer. Adv. Drug Deliv. Rev. 2008, 60:1329-1346.
4. Ogihara I., Kojima S., Jay M. Differential uptake of gallium-67-labeled liposomes between tumors and inflammatory lesions in rats. J.Nucl. Med. 1986, 27:1300-1307.
5. Bao A., Goins B., Klipper R., Negrete G., Mahindaratne M., Phillips W.T. Anovel liposome radiolabeling method using Tc-99m-"SNS/S" complexes: Invitro and invivo evaluation. J.Pharm. Sci. 2003, 92:1893-1904.
6. Mitra A., Nan A., Line B.R., Ghandehari H. Nanocarriers for nuclear imaging and radiotherapy of cancer. Curr. Pharm. Des. 2006, 12:4729-4749.
7. Chang Y.-J., Chang C.-H., Yu C.-Y., Chang T.-J., Chen L.-C., Chen M.-H., et al. Therapeutic efficacy and microSPECT/CT imaging of Re-188-DXR-liposome in a C26 murine colon carcinoma solid tumor model. Nucl. Med. Biol. 2010, 37:95-104.
8. Zhao W., Robbins M.E.C. Inflammation and chronic oxidative stress in radiation-induced late normal tissue injury: therapeutic implications. Curr. Med. Chem. 2009, 16:130-143.
9. Ting G., Chang C.-H., Wang H.-E., Lee T.-W. Nanotargeted radionuclides for cancer nuclear imaging and internal radiotherapy. J.Biomed. Biotechnol. 2010, 2010.
10. Davis M.E., Chen Z., Shin D.M. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat. Rev. Drug Discov. 2008, 7:771-782.
11. Huber P.E., Bischof M., Jenne J., Heiland S., Peschke P., Saffrich R., et al. Trimodal cancer treatment: Beneficial effects of combined antianglogenesis, radiation, and chemotherapy. Cancer Res. 2005, 65:3643-3655.
12. Ting G., Chang C.-H., Wang H.-E. Cancer Nanotargeted Radiopharmaceuticals for Tumor Imaging and Therapy. Anticancer Res. 2009, 29:4107-4118.
13. Zhang L., Chen H., Wang L., Liu T., Yeh J., Lu G., et al. Delivery of therapeutic radioisotopes using nanoparticle platforms: potential benefit in systemic radiation therapy. Nanotechnology 2010, 3:159-170.
14. Liu Y., Yin J.-J., Nie Z. Harnessing the collective properties of nanoparticle ensembles for cancer theranostics. Nano Res. 2014, 7:1719-1730.
15. Tang S., Chen M., Zheng N. Multifunctional ultrasmall Pd nanosheets for enhanced near-infrared photothermal therapy and chemotherapy of cancer. Nano Res. 2015, 8:165-174.
16. Chung C., Kim Y.-K., Shin D., Ryoo S.-R., Hong B.H., Min D.-H. Biomedical Applications of Graphene and Graphene Oxide. Acc. Chem. Res. 2013, 46:2211-2224.
17. Yang K., Feng L., Shi X., Liu Z. Nano-graphene in biomedicine: theranostic applications. Chem. Soc. Rev. 2013, 42:530-547.
18. Zhang L., Xia J., Zhao Q., Liu L., Zhang Z. Functional Graphene Oxide as a Nanocarrier for Controlled Loading and Targeted Delivery of Mixed Anticancer Drugs. Small 2010, 6:537-544.
19. Yang X., Niu G., Cao X., Wen Y., Xiang R., Duan H., et al. The preparation of functionalized graphene oxide for targeted intracellular delivery of siRNA. J.Mater Chem. 2012, 22:6649-6654.
20. Yang X., Wang Y., Huang X., Ma Y., Huang Y., Yang R., et al. Multi-functionalized graphene oxide based anticancer drug-carrier with dual-targeting function and pH-sensitivity. J.Mater Chem. 2011, 21:3448-3454.
21. Yang X., Zhang X., Liu Z., Ma Y., Huang Y., Chen Y. High-Efficiency Loading and Controlled Release of Doxorubicin Hydrochloride on Graphene Oxide. J.Phys Chem. C 2008, 112:17554-17558.
22. Yang X., Zhang X., Ma Y., Huang Y., Wang Y., Chen Y. Superparamagnetic graphene oxide-Fe(3)O(4) nanoparticles hybrid for controlled targeted drug carriers. J.Mater Chem. 2009, 19:2710-2714.
23. Tian B., Wang C., Zhang S., Feng L., Liu Z. Photothermally Enhanced Photodynamic Therapy Delivered by Nano-Graphene Oxide. ACS Nano 2011, 5:7000-7009.
24. Jung J.H., Cheon D.S., Liu F., Lee K.B., Seo T.S. AGraphene Oxide Based Immuno-biosensor for Pathogen Detection. Angew. Chem. Int. Ed. 2010, 49:5708-5711.
25. Miao W., Shim G., Lee S., Lee S., Choe Y.S., Oh Y.-K. Safety and tumor tissue accumulation of pegylated graphene oxide nanosheets for co-delivery of anticancer drug and photosensitizer. Biomaterials 2013, 34:3402-3410.
26. Miao W., Shim G., Kang C.M., Lee S., Choe Y.S., Choi H.-G., et al. Cholesteryl hyaluronic acid-coated, reduced graphene oxide nanosheets for anti-cancer drug delivery. Biomaterials 2013, 34:9638-9647.
27. Shim G., Kim J.-Y., Han J., Chung S.W., Lee S., Byun Y., et al. Reduced graphene oxide nanosheets coated with an anti-angiogenic anticancer low-molecular-weight heparin derivative for delivery of anticancer drugs. J.Controll. Release 2014, 189:80-89.
28. Feng L., Wu L., Qu X. New horizons fro diagnosis and therapeutic applications of graphene and graphene oxide. Adv. Mater 2013, 168-186.
29. Yan L., Zheng Y.B., Zhao F., Li S., Gao X., Xu B., et al. Chemistry and physics of a single atomic layer: strategies and challenges for functionalization of graphene and graphene-based materials. Chem. Soc. Rev. 2012, 97-114.
30. Liu Y., Zhao Y., Sun B., Chen C. Understanding the Toxicity of Carbon Nanotubes. Accounts of Chemical Research. Acc. Chem. Res. 2013, 46:702-713.
31. Li Y., Liu Y., Fu Y., Wei T., Guyader L.L., Gao G., et al. The triggering of apoptosis in macrophages by pristine graphene through the MAPK and TGF-beta signaling pathways. Biomateirals 2012, 33:402-411.
32. Kostarelos K., Novoselov K.S. Graphene devices for life. Nat. Nanotechnol. 2014, 9:744-745.
33. Kostarelos K., Novoselov K. Exploring the Interface of Graphene and Biology. Science 2014, 261-263.
34. Bussy C., Ali-Boucetta H., Kostarelos K. Safety considerations for graphene: lessons learnt from carbon nanotubes. Acc. Chem. Res. 2013, 25:2258-2268.
35. Chen Y., Chen P., Hu S., Chen I., Chen S. NIR-Triggered Synergic Photo-chemothermal Therapy Delivered by Reduced Graphene Oxide/Carbon/Mesoporous Silica Nanocookies. Adv. Funct. Mater 2014, 24:451-459.
36. Wang S., Zhang Q., Luo X., Li J., He H., Yang F., et al. Magnetic graphene-based nanotheranostic agent for dual-modality mapping guided photothermal therapy in regional lymph nodal metastasis of pancreatic cancer. Biomaterials 2014, 35(35):9473-9483.
37. Bai J., Liu Y., Jiang X. Multifunctional PEG-GO/CuS nanocomposites for near-infrared chemo-photothermal therapy. Biomaterials 2014, 35(22):5808-5813.
38. Yang Y., Asiri A., Tang Z., Du Z., Lin Y. Graphene based materials for biomedical applications. Mater Today 2013, 16(10):365-373.
39. Jin Y., Wang J., Ke H., Wang S., Dai Z. Graphene oxide modified PLA microcapsules containing gold nanoparticles for ultrasonic/CT bimodal imaging guided photothermal tumor therapy. Biomaterials 2013, 34(20):4794-4802.
40. Zhang X., Yin J., Peng C., Hu W., Zhu Z., Li W., et al. Distribution and biocompatibility studies of graphene oxide in mice after intravenous administration. Carbon 2011, 49:986-995.
41. Wang K., Ruan J., Song H., Zhang J., Wo Y., Guo S., et al. Biocompatibility of Graphene Oxide. Nanoscale Res. Lett. 2011, 6.
42. Singh S.K., Singh M.K., Kulkarni P.P., Sonkar V.K., Gracio J.J.A., Dash D. Amine-Modified Graphene. Thrombo-Protective Safer Alternative to Graphene Oxide for Biomedical Applications. ACS Nano 2012, 6:2731-2740.
43. Singh S.K., Singh M.K., Nayak M.K., Kumari S., Shrivastava S., Gracio J.J.A., et al. Thrombus Inducing Property of Atomically Thin Graphene Oxide Sheets. ACS Nano 2011, 5:4987-4996.
44. Bianco A. Graphene: safe or toxic? The two faces of the medal. Angew. Chem. Int. Ed. 2013, 52:4986-4997.
45. Russier J., Treossi E., Scarsi A., Perrozzi F., Dumortier H., Ottaviano L., et al. Evidencing the mask effect of graphene oxide: a comparative study on primary human and murine phagocytic cells. Nanoscale 2013, 5:11234-11247.
46. Duch M.C., Budinger G.R.S., Liang Y.T., Soberanes S., Urich D., Chiarella S.E., et al. Minimizing Oxidation and Stable Nanoscale Dispersion Improves the Biocompatibility of Graphene in the Lung. Nano Lett. 2011, 11:5201-5207.
47. Yang K., Wan J.M., Zhang S.A., Zhang Y.J., Lee S.T., Liu Z.A. InVivo Pharmacokinetics, Long-Term Biodistribution, and Toxicology of PEGylated Graphene in Mice. ACS Nano 2011, 5:516-522.
48. Hong H., Yang K., Zhang Y., Engle J.W., Feng L., Yang Y., et al. InVivo Targeting and Imaging of Tumor Vasculature with Radiolabeled, Antibody-Conjugated Nanographene. ACS Nano 2012, 6:2361-2370.
49. Hong H., Zhang Y., Engle J.W., Nayak T.R., Theuer C.P., Nickles R.J., et al. Invivo targeting and positron emission tomography imaging of tumor vasculature with Ga-66-labeled nano-graphene. Biomaterials 2012, 33:4147-4156.
50. Yang K., Wan J., Zhang S., Tian B., Zhang Y., Liu Z. The influence of surface chemistry and particle size of nanoscale graphene oxide on photothermal therapy of cancer using ultra-low laser power. Biomatreials 2012, 33:2206-2214.
51. 131I SPECT/spiral CT on nodal staging of differentiated thyroid carcinoma at the first radioablation. J.Nucl. Med. 2009, 50:18-23.
52. Yang K., Zhang S., Zhang G., Sun X., Lee S.-T., Liu Z. Graphene in Mice: ultra-high invivo tumor uptake and photothermal therapy. Nano Lett. 2010, 10:3318-3323.